A critical first step in achieving the 90-90-90 targets proposed by UNAIDS is ensuring that 90 percent of all people living with HIV will know their HIV status by 2020. This is an ambitious goal, as currently only half of people living with HIV know their status. The recently released WHO HIV testing guidelines address and respond to this reality. The WHO’s Dr. Rachel Baggaley, unpacked the HIV testing guidelines and highlighted the need-to-know specifics of the new guidelines.

Listen to the recording here.

View the slides here.

Following the recent announcement of new guidelines by WHO, this webinar looked at the implications of treatment for all for HIV prevention programmes.

Speakers included Professor Jens Lundgren, one of the principal investigators of the START study; Dr Meg Doherty, Coordinator of Treatment and Care in the Department of HIV/AIDS at WHO, and Giulio Maria Corbelli, Chair of the European Community Advisory Board (ECAB).

The webinar was chaired by Gus Cairns of EATG.

This series of three webinars, hosted jointly by EATG and AVAC, is designed to prepare and update EATG members for a special meeting on new developments in prevention on 23-25th January 2015 in Brussels. 

The first webinar addressed the latest updates on treatment as prevention. Speakers included Dr. Reuben Granich, Senior Advisor for Care and Treatment at UNAIDS, Dr. Sarah Fidler of Imperial College London, and Silvia Petretti, Deputy CEO of Positively UK.

In Melbourne, UNAIDS launched a new initiative known as “90-90-90”, which lays out new targets for testing, treatment and virologic suppression. Where did these targets come from, what do they mean—and where does prevention fit in? Chris Collins, Chief of the Community Mobilization Division at UNAIDS addressed these questions and more.

This was the third webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC. We were joined by an expert panel discussing treatment as prevention, who took questions following their presentations. To view the full Flash animation of the webinar, click here.

Hosted jointly by NAM and AVAC, the last webinar for 2013 in our series addressed a range of topics in HIV prevention research, including the development of the EATG/NAM community consensus statement on treatment as prevention, a set of principles intended to guide policy on access to antiretroviral therapy for prevention purposes for people with HIV, to be launched in January.

To view the full Flash animation of the webinar, click here.

Thousands of community leaders, front-line workers, policy makers, physicians and advocates from throughout the US met for the United States Conference on AIDS (USCA). What follows is a short list of biomedical HIV prevention research and implementation-related sessions and links to the Black Treatment Action Network/PxROAR Advocates’ Roadmap and full conference program. (The Black Treatment Action Network is a project of the Black AIDS Institute.)

The BTAN/PxROAR Advocates’ Roadmap highlights workshops, seminars and roundtables on a range of issues such as HIV prevention advocacy, access to treatment, linkage to care and the treatment cascade. Advocates who attend Roadmap sessions at the conference are eligible for prizes. Click here for more information.

Sessions of interest for biomedical HIV prevention advocates included:

Saturday, September 7

• National Black Treatment Advocates Network pre-conference session: “Reaching Viral Suppression in the Black South”.

Sunday, September 8

• Workshop: Structural-level Interventions for HIV Prevention – Strategies for program implementation.
• Workshop: An HIV Cure: How close are we?.

Monday, September 9

• Workshop: Separating Hype from Hope: How to answer clients’ questions about HIV treatment and prevention headlines.

• Workshop: Pre-Exposure Prophylaxis (PrEP): The science and experiences with practical application.

• Workshop: Biomedical HIV Prevention as a Comprehensive Approach to Reaching an AIDS Free Generation.

Tuesday, September 10

• Seminar: Women and HIV Prevention Research: How is the HIV Prevention Trials Network working to bridge gaps in research for women in the United States and around The world?.

• Workshop: PrEP Messaging.

• Roundtable: Lessons from the Community: Engaging women in HIV prevention research advocacy.

Wednesday, September 11

• Seminar: HIV Intervention and Prevention With Black Men who have Sex with Men: A research and policy dialogue.

• Seminar: We’re In It Together: Formal & informal networks for accessing PrEP dialogs and community perspective on treatment as prevention (a joint presentation).

On June 30, the World Health Organization (WHO) released updated Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. AVAC, Global Network of People of Living with HIV (GNP+), the International HIV/AIDS Alliance (Alliance), and STOP AIDS NOW! (SAN!) held a webinar to discuss the guidelines and a new tool—Community Guide to Treatment as Prevention Programming.

The call included a brief overview of the guidelines by Gottfried Hirnschall, the Director of the Department of HIV/AIDS at WHO, as well as other resource people who were involved in the development of the guidelines and are engaged in translating these guidelines into practice.

In addition, Moono Nyambe from GNP+ discussed the “community” reactions toward the guidelines and described the collaborative effort led by GNP+, Alliance and SAN! to develop the Community Guide (to help communities understand the substance of the WHO guidelines and get involved in programming and implementation at country level).